Augmentation of the EPR effect by mild hyperthermia to improve nanoparticle delivery to the tumor
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2024
DOI: 10.1016/j.bbcan.2024.189109 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2024. Verfasst von Kenan Aloss und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Translational Medicine - Semmelweis University - 1094, Tűzoltó utca, 37-49, Budapest, Hungary. Hauptthemen laut MEDLINE: Neoplasms, Hyperthermia, Induced, Nanoparticles. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 250 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nemzeti Kutatási Fejlesztési és Innovációs Hivatal, Tempus Közalapítvány.
Abstract (Originalsprache)
The clinical translation of the nanoparticle (NP)-based anticancer therapies is still unsatisfactory due to the heterogeneity of the enhanced permeability and retention (EPR) effect. Despite the promising preclinical outcome of the pharmacological EPR enhancers, their systemic toxicity can limit their clinical application. Hyperthermia (HT) presents an efficient tool to augment the EPR by improving tumor blood flow (TBF) and vascular permeability, lowering interstitial fluid pressure (IFP), and disrupting the structure of the extracellular matrix (ECM). Furthermore, the HT-triggered intravascular release approach can overcome the EPR effect. In contrast to pharmacological approaches, HT is safe and can be focused to cancer tissues. Moreover, HT conveys direct anti-cancer effects, which improve the efficacy of the anti-cancer agents encapsulated in NPs. However, the clinical application of HT is challenging due to the heterogeneous distribution of temperature within the tumor, the length of the treatment and the complexity of monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Translational Medicine - Semmelweis University - 1094, Tűzoltó utca, 37-49, Budapest, Hungary.
- Institute of Translational Medicine - Semmelweis University - 1094, Tűzoltó utca, 37-49, Budapest, Hungary. Electronic address: Hamar.peter@semmelweis.hu.
Förderung
- Nemzeti Kutatási Fejlesztési és Innovációs Hivatal
- Tempus Közalapítvány
Zitieren
APA
Aloss, K., & Hamar, P. (2024). Augmentation of the EPR effect by mild hyperthermia to improve nanoparticle delivery to the tumor. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2024.189109
Vancouver
Aloss K, Hamar P. Augmentation of the EPR effect by mild hyperthermia to improve nanoparticle delivery to the tumor. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2024. doi:10.1016/j.bbcan.2024.189109
BibTeX
@article{Aloss2024,
author = {Aloss, Kenan and Hamar, Péter},
title = {Augmentation of the EPR effect by mild hyperthermia to improve nanoparticle delivery to the tumor},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2024},
doi = {10.1016/j.bbcan.2024.189109}
}
EUVIMED